Dooku1
Dooku1 is a reversibly Yoda1 antagonist with IC50 value of 1.3 μM and 1.5 μM for 2 μM Yoda1-induced Ca2+ entry HEK 293 cells and HUVECs, respectively. Dooku1 can disrupt Yoda1-induced Piezo1 channel activity and inhibit Yoda1-induced relaxation of aorta. Dooku1 can be used for vascular physiology and disease research[1].
Product Specifications
CAS Number
2253744-54-4
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
Piezo Channel
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel
Applications
COVID-19-immunoregulation
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/dooku1.html
Purity
99.93
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
ClC1=C(C(Cl)=CC=C1)CSC2=NN=C(C3=CC=CN3)O2
Molecular Formula
C13H9Cl2N3OS
Molecular Weight
326.20
Precautions
H315, H319, H335
References & Citations
[1]Evans EL, et al. Yoda1 analogue (Dooku1) which antagonizes Yoda1-evoked activation of Piezo1 and aortic relaxation. Br J Pharmacol. 2018 May;175 (10) :1744-1759.|[2]Evans EL, et al. Yoda1 analogue (Dooku1) which antagonizes Yoda1-evoked activation of Piezo1 and aortic relaxation. Br J Pharmacol. 2018 May;175 (10) :1744-1759.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
B2017394 25 mg
L-α-Phosphatidyl-L-serine from Glycine max (soybean)
Sign In for Pricing
View Details 